抗U1RNP系统性硬化症患者的间歇性肺病:欧洲硬化体试验和研究分析
Gonçalo Boleto1,2, Corrado Campochiaro3, Oliver Distler4
1Service de Rhumatologie, Cochin Hospital, APHP, Universite Paris Cité, Centre de Référence Maladies Autoimmunes Systémiques Rares d'Ile de France, Paris, France.
Journal of scleroderma and related disorders
|March 24, 2025
概括
患有系统性硬化症相关的间歇性肺病和抗U1RNP抗体的患者初始肺功能较差. 然而,他们的疾病进展和死亡率与没有这些抗体的人在三年内相似.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
背景情况:
- 间歇性肺病 (ILD) 是系统性硬化症 (SSc) 的主要并发症,导致显著的发病率和死亡率.
- 在SSc-ILD中,患者的治疗结果是高度可变的,并且特定的自身抗体 (如抗U1RNP) 对肺部参与的影响仍然不清楚.
研究的目的:
- 研究抗U1RNP抗体对SSc-ILD患者肺功能和疾病进展的影响.
- 为了比较基线特征,纵向肺功能变化和抗U1RNP阳性和阴性SSc-ILD患者之间的死亡率.
主要方法:
- 分析了来自欧洲硬质皮肤炎试验和研究小组的6043名SSc-ILD患者的数据.
- 对抗U1RNP阳性和阴性组之间的人口和疾病特征的比较,包括基线强迫生命能力 (FVC) 和一氧化碳扩散能力 (DLCO).
- 在36个月内对FVC变化进行纵向分析,并使用逻辑回归和Cox比例危险模型评估死亡率预测因素.
主要成果:
- 5.4%的SSc-ILD患者是抗U1RNP阳性的.
- 抗U1RNP阳性患者表现出更有限的皮肤SSc,更高的突炎和肌炎率,以及较差的基线肺功能 (较低的FVC和DLCO).
- 在随访期间,在抗U1RNP阳性和阴性组之间,没有观察到轻度或重度FVC下降率或总死亡率的统计学上显著差异.
结论:
- 在SSc-ILD中抗U1RNP抗体与更差的基线肺功能有关.
- 尽管存在最初的差异,但抗U1RNP阳性似乎并不能预测SSc-ILD患者在前三年随访期间加速FVC下降或增加死亡率.
相关概念视频
01:24Chronic Obstructive Pulmonary Disease
3.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40